Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
250 25th Ave., N
Suite 200
Nashville, TN 37203Phone+1 615-320-5090- Is this information wrong?
Summary
- Dr. Melissa Johnson is the Director of the Lung Cancer Research Program at Sarah Cannon Research Institute and the Associate Director of the Drug Development Unit in Nashville. She is also a partner in Tennessee Oncology, PLLC. She is a medical oncologist affiliated with TriStar Centennial Medical Center. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 13 years. She specializes in thoracic oncology and clinical trial investigation.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
- Perelman School of Medicine at the University of PennsylvaniaClass of 2004
Certifications & Licensure
- FL State Medical License 2020 - Present
- TN State Medical License 2021 - 2025
- TN State Medical License 2014 - 2025
- LA State Medical License 2020 - 2022
- AL State Medical License 2020 - 2020
- IL State Medical License 2010 - 2017
- NY State Medical License 2006 - 2011
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
- LDE225 for Patients With PTCH1 or SMO Mutated Tumors Start of enrollment: 2014 Feb 01
- A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer Start of enrollment: 2019 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Tcells.Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis...> ;Nature. 2024 Mar 13
- Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Tcells.Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta, Ellen Duong, Alexis...> ;Nature. 2024 Mar 1
- A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.Riely, G., Smit, E., Ahn, M., Felip, E., Ramalingam, S., Tsao, A., Johnson, M., Gelsomino, F., Esper, R., Nadal, E., Offin, M., Provencio, M., Clarke, J., Hussein, M.,...> ;Future Oncology. 2024 Feb 15
- Join now to see all
Lectures
- A phase I, open label, multicenter dose escalation study of AZD2811 nanoparticle in patients with advanced solid tumors.ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
- A phase I, open-label, multicenter dose escalation study to assess the safety, tolerability, and pharmacokinetics of AZD2811 nanoparticle in patients with advanced sol...2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- First in human phase 1/2a study of PEN-221 somatostatin analog (SSA)-DM1 conjugate for patients (PTS) with advanced neuroendocrine tumor (NET) or small cell lung cance...2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
- Join now to see all
Press Mentions
- Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009January 4th, 2023
- Domvanalimab-Containing Regimens Show Activity in PD-L1-High NSCLCDecember 28th, 2022
- AstraZeneca’s Imfinzi with Imjudo Approved in the US for NSCLCNovember 11th, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- TriStar Centennial Medical CenterNashville, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: